- Resource Centers
Q How do I go about compounding either lidocaine/prilocaine/epinephrine or benzocaine/tetracaine/lidocaine? A plastic surgeon needs either one as a numbing cream.
A A variety of topical formulations for anesthesia for laser surgery are found in the literature. One of the more common ones is a variation of the following suggestion that you might find quite useful.
Lidocaine forms a eutectic with prilocaine, an advantage when incorporation of both ingredients into topical formulations is required. Lidocaine is rapidly absorbed from the gastrointestinal system and mucous membranes and through broken skin. It is only poorly absorbed through intact skin. Physicians should be cautioned that these formulations can yield relatively rapid anesthesia from the -caine anesthetics. Transdermal formulations of lidocaine, particularly, applied in high concentrations over extensive areas may produce acute overdose symptoms. The health care providers involved with these procedures should consult current literature and use professional judgment when applying the formulations.
Prilocaine is considered to be the least toxic of the amide-type local anesthetics. It is considerably protein-bound and undergoes hepatic metabolism.
Benzocaine is a para-aminobenzoic acid ester. It has low potency and low systemic toxicity. It is used on the skin or mucous membranes for topical anesthesia. Hydrolysis by esterases occurs primarily in the plasma and also in the liver. Tetracaine (amethocaine is the British nomenclature) also is a para-aminobenzoic acid ester and has potent local anesthetic action. It has high systemic toxicity and is rapidly absorbed from mucous membranes. Toxic symptoms can occur abruptly. Topically, 0.5% to 1% creams and ointments are used rectally. For anesthesia before venipuncture, a 4% preparation has been applied. In the latter case, application under a dressing for 30 minutes generally provides surface anesthesia for 4 to 6 hours.
Epinephrine, a direct-acting sympathomimetic, sometimes is used in these formulations to slow the rate of diffusion and to limit absorption, thus reducing the potential for toxicity.
Laser Therapy Gel
Calculated to make 100 mL
Thick Aid contains sodium acrylate/sodium acryloyldimethyl taurate copolymer, hydrogenated polydecene, and Laureth-8. Thick Aid is activated by the presence of water.
E-mail your compounding questions to email@example.com
Mr. Erickson is director of professional affairs at Gallipot Inc.